KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Travere Therapeutics (TVTX) over the last 13 years, with Q3 2025 value amounting to $10.3 million.

  • Travere Therapeutics' Other Non-Current Assets fell 4010.75% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year decrease of 4010.75%. This contributed to the annual value of $18.2 million for FY2024, which is 7035.93% up from last year.
  • Per Travere Therapeutics' latest filing, its Other Non-Current Assets stood at $10.3 million for Q3 2025, which was down 4010.75% from $19.6 million recorded in Q2 2025.
  • Travere Therapeutics' 5-year Other Non-Current Assets high stood at $48.3 million for Q4 2022, and its period low was $10.3 million during Q3 2025.
  • For the 5-year period, Travere Therapeutics' Other Non-Current Assets averaged around $19.1 million, with its median value being $16.9 million (2024).
  • Per our database at Business Quant, Travere Therapeutics' Other Non-Current Assets skyrocketed by 41491.99% in 2021 and then tumbled by 7794.67% in 2023.
  • Quarter analysis of 5 years shows Travere Therapeutics' Other Non-Current Assets stood at $11.1 million in 2021, then soared by 336.73% to $48.3 million in 2022, then tumbled by 77.95% to $10.7 million in 2023, then soared by 70.36% to $18.2 million in 2024, then plummeted by 43.55% to $10.3 million in 2025.
  • Its Other Non-Current Assets stands at $10.3 million for Q3 2025, versus $19.6 million for Q2 2025 and $18.7 million for Q1 2025.